RhumbLine Advisers’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26,294
| Closed | -$438K | – | 2875 |
|
|
2017
Q3 | $438K | Buy |
26,294
+285
| +1% | +$4.63K | ﹤0.01% | 2377 |
|
|
2017
Q2 | $466K | Sell |
26,009
-304
| -1% | -$5.68K | ﹤0.01% | 2344 |
|
|
2017
Q1 | $528K | Buy |
26,313
+706
| +3% | +$16.4K | ﹤0.01% | 2220 |
|
|
2016
Q4 | $641K | Sell |
25,607
-723
| -3% | -$17.1K | ﹤0.01% | 2100 |
|
|
2016
Q3 | $615K | Buy |
26,330
+490
| +2% | +$11.5K | ﹤0.01% | 2080 |
|
|
2016
Q2 | $517K | Sell |
25,840
-6,597
| -20% | -$123K | ﹤0.01% | 2175 |
|
|
2016
Q1 | $549K | Buy |
32,437
+3,700
| +13% | +$75.8K | ﹤0.01% | 2164 |
|
|
2015
Q4 | $638K | Buy |
28,737
+475
| +2% | +$9.89K | ﹤0.01% | 2088 |
|
|
2015
Q3 | $480K | Buy |
28,262
+1,579
| +6% | +$24.6K | ﹤0.01% | 2250 |
|
|
2015
Q2 | $367K | Sell |
26,683
-1,965
| -7% | -$26.1K | ﹤0.01% | 2526 |
|
|
2015
Q1 | $392K | Buy |
28,648
+1,400
| +5% | +$16.2K | ﹤0.01% | 2445 |
|
|
2014
Q4 | $288K | Buy |
27,248
+2,475
| +10% | +$29.3K | ﹤0.01% | 2609 |
|
|
2014
Q3 | $310K | Sell |
24,773
-80
| -0.3% | -$1.11K | ﹤0.01% | 2500 |
|
|
2014
Q2 | $340K | Buy |
24,853
+857
| +4% | +$11.2K | ﹤0.01% | 2515 |
|
|
2014
Q1 | $290K | Sell |
23,996
-970
| -4% | -$11.1K | ﹤0.01% | 2554 |
|
|
2013
Q4 | $307K | Sell |
24,966
-1,800
| -7% | -$21.1K | ﹤0.01% | 2573 |
|
|
2013
Q3 | $272K | Sell |
26,766
-106
| -0.4% | -$991 | ﹤0.01% | 2600 |
|
|
2013
Q2 | $241K | Buy |
+26,872
| New | +$271K | ﹤0.01% | 2838 |
|
RhumbLine Advisers's OME Position: Q4 2017 in Review
RhumbLine Advisers sold out of Omega Protein (OME) in Q4 2017, closing a stake of 26,294 shares — an estimated $438K sold.
RhumbLine Advisers first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $641K in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- RhumbLine Advisers reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- RhumbLine Advisers sold 26,294 Omega Protein shares in Q4 2017, an estimated $438K.
- RhumbLine Advisers first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- RhumbLine Advisers's Omega Protein position peaked at $641K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.